Clinical trial
Three New Methods for Diagnosing Pancreas Cancer
NCT00259532 · University of Copenhagen, Other · Unknown status
Key facts
| NCT number | NCT00259532 |
|---|---|
| Title | Three New Methods for Diagnosing Pancreas Cancer |
| Official title | Ultrasound With Contrast Agent, 64-Slice-CT and Tumormarkers for Diagnosing, Evaluation of Operability and Treatment Control of Pancreas Cancer |
| Lead sponsor | University of Copenhagen, Other |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Pancreas Cancer |
| Intervention type | Procedure |
| Interventions | Ultrasound and contrast agent |
| Enrollment | 80 |
| Start date | Feb 1, 2005 |
| Completion | Jan 1, 2009 |
| First posted | Nov 29, 2005 |
| Last update posted | Feb 26, 2009 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: